News
Hf Foods Group Q1 Earnings Call Highlights
Hf Foods Group (NASDAQ:HFFG) reported higher first-quarter revenue and improved profitability as management said volume growth, cost controls and operational changes helped offset pressure from
Health Catalyst Q1 Earnings Call Highlights
Health Catalyst (NASDAQ:HCAT) reported first-quarter 2026 results that topped its own expectations, while management outlined a broad
Halozyme Therapeutics Q1 Earnings Call Highlights
Halozyme Therapeutics (NASDAQ:HALO) reported a sharp increase in first-quarter 2026 revenue and earnings, driven by continued growth in royalties from its ENHANZE drug-delivery platform, and
GoPro Q1 Earnings Call Highlights
GoPro (NASDAQ:GPRO) said it has begun a strategic review after receiving inbound merger-and-acquisition interest tied to its
Stellus Capital (SCM) Q1 Earnings Meet Estimates
Stellus Capital (SCM) came out with quarterly earnings of $0.27 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.37 per share a year ago. These figures are
Star Equity Holdings (STRR) Reports Q1 Loss, Misses Revenue Estimates
Star Equity Holdings (STRR) came out with a quarterly loss of $0.99 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.46 per share a year ago. These
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
Si-Bone (SIBN) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago. These figures are
Pangaea Logistics (PANL) Q1 Earnings and Revenues Beat Estimates
Pangaea Logistics (PANL) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $0.03 per share a year ago. These
Ovintiv (OVV) Q1 Earnings and Revenues Beat Estimates
Ovintiv (OVV) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.85 per share. This compares to earnings of $1.42 per share a year ago. These figures are
Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates
Metagenomi Therapeutics (MGX) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.6. This compares to a loss of $0.68 per share a year ago. These
Satellogic Inc. (SATL) Reports Q1 Loss, Lags Revenue Estimates
Satellogic Inc. (SATL) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.16 per share a year ago. These figures
Ramaco Resources (METC) Reports Q1 Loss, Misses Revenue Estimates
Ramaco Resources (METC) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.19 per share a year ago. These figures
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
Bioceres Crop (BIOX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.02 per share a year ago. These figures
KORE Group Holdings, Inc. (KORE) Reports Q1 Loss, Lags Revenue Estimates
KORE Group Holdings, Inc. (KORE) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.77 per share a year ago
Integra Resources Corp. (ITRG) Q1 Earnings Lag Estimates
Integra Resources Corp. (ITRG) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.03 per share a year ago
Exodus Movement, Inc. (EXOD) Reports Q1 Loss, Lags Revenue Estimates
Exodus Movement, Inc. (EXOD) came out with a quarterly loss of $1.08 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.45 per share a year ago. These
3D Systems (DDD) Reports Q1 Loss, Beats Revenue Estimates
3D Systems (DDD) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.21 per share a year ago. These figures are
Agenus (AGEN) Q1 Earnings and Revenues Miss Estimates
Agenus (AGEN) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $2.1 per share. This compares to a loss of $1.03 per share a year ago. These figures are
AlTi Global, Inc. (ALTI) Q1 Earnings and Revenues Beat Estimates
AlTi Global, Inc. (ALTI) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago. These
Almonty Industries Inc. (ALM) Meets Q1 Earnings Estimates
Almonty Industries Inc. (ALM) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $0.02 per share a year ago. These figures
Need a List of AI Stocks? Use This Zacks Tool
Zacks Thematic Screens lets you dive into 30 dynamic investment themes shaping the future. Whether you're interested in cutting-edge technology, renewable energy, or healthcare innovations, our
Viant Technology Q1 Earnings Call Highlights
Viant Technology (NASDAQ:DSP) reported record first-quarter 2026 results and said it expects growth to accelerate through the year, citing strong connected TV demand, new customer ramps, artificial
DocGo Q1 Earnings Call Highlights
DocGo (NASDAQ:DCGO) reported first-quarter revenue of $75.6 million and an adjusted EBITDA loss of $10.2 million, as executives pointed to accelerating
CVRx Q1 Earnings Call Highlights
CVRx (NASDAQ:CVRX) reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high
Coherus Oncology Q1 Earnings Call Highlights
Coherus Oncology (NASDAQ:CHRS) said it expects revenue growth for its nasopharyngeal cancer drug LOQTORZI to build through the rest of 2026, while the company prepares for multiple clinical data